AGC will increase its contract manufacturing business CMC Biologics in Berkeley, California, by expanding manufacturing capacity, with an investment of over 10 billion Yen. The company aims at sales of 100 billion Yen in 2025 in this business field.

AGC news release, December 18, 2018